News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
24,071 Results
Type
Article (1058)
Company Profile (1)
Press Release (23012)
Section
Business (11986)
Career Advice (19)
Deals (1628)
Drug Delivery (6)
Drug Development (2036)
FDA (294)
Job Trends (495)
News (15089)
Policy (580)
Tag
Academia (27)
Accelerated approval (2)
Adcomms (1)
Allergies (3)
Alliances (748)
ALS (3)
Alzheimer's disease (40)
Antibody-drug conjugate (ADC) (6)
Approvals (309)
Artificial intelligence (4)
Autoimmune disease (5)
Bankruptcy (13)
Best Places to Work (391)
Biosimilars (3)
Biotechnology (1)
Bladder cancer (3)
Brain cancer (2)
Breast cancer (11)
Cancer (134)
Cardiovascular disease (7)
Career advice (18)
CAR-T (2)
Cell therapy (8)
Clinical research (1904)
Collaboration (20)
Compensation (18)
COVID-19 (29)
CRISPR (2)
C-suite (7)
Cystic fibrosis (1)
Data (219)
Depression (4)
Dermatology (2)
Diabetes (18)
Diagnostics (210)
Digital health (2)
Drug discovery (3)
Drug pricing (8)
Duchenne muscular dystrophy (3)
Earnings (11654)
Editorial (1)
Events (2644)
Executive appointments (2)
FDA (470)
Frontotemporal dementia (1)
Funding (22)
Gene editing (3)
Gene therapy (8)
GLP-1 (36)
Government (43)
Grass and pollen (1)
Guidances (120)
Healthcare (562)
HIV (2)
IgA nephropathy (2)
Immunology and inflammation (8)
Immuno-oncology (2)
Indications (6)
Infectious disease (36)
Inflammatory bowel disease (4)
Influenza (5)
Intellectual property (3)
Interviews (3)
IPO (1256)
IRA (2)
Job creations (118)
Job search strategy (17)
Labor market (4)
Layoffs (8)
Leadership (1)
Legal (129)
Lung cancer (42)
Lymphoma (28)
Manufacturing (12)
MASH (9)
Medical device (527)
Medtech (531)
Mergers & acquisitions (385)
Metabolic disorders (45)
mRNA (2)
Multiple sclerosis (6)
NASH (1)
Neurodegenerative disease (6)
Neuropsychiatric disorders (4)
Neuroscience (76)
NextGen: Class of 2026 (169)
Non-profit (51)
Now hiring (2)
Obesity (22)
Opinion (5)
Pain (7)
Pancreatic cancer (3)
Parkinson's disease (12)
Patents (4)
Patient recruitment (2)
Peanut (1)
People (762)
Phase 1 (487)
Phase 2 (745)
Phase 3 (795)
Pipeline (675)
Policy (6)
Postmarket research (70)
Preclinical (136)
Prostate cancer (5)
Radiopharmaceuticals (7)
Rare diseases (19)
Real estate (128)
Regulatory (480)
Reports (3)
Research institute (23)
Resumes & cover letters (2)
Rett syndrome (1)
RNA editing (1)
Schizophrenia (7)
Series A (1)
Series B (2)
Sickle cell disease (1)
Spinal muscular atrophy (11)
Startups (77)
Tariffs (2)
The Weekly (1)
Vaccines (19)
Weight loss (16)
Women's health (5)
Date
Today (11)
Last 7 days (32)
Last 30 days (77)
Last 365 days (1216)
2026 (381)
2025 (1255)
2024 (1339)
2023 (1587)
2022 (1871)
2021 (1899)
2020 (1616)
2019 (1274)
2018 (1033)
2017 (790)
2016 (383)
2015 (6962)
2014 (440)
2013 (248)
2012 (274)
2011 (333)
2010 (374)
Location
Africa (19)
Alabama (2)
Arizona (4)
Asia (1339)
Australia (188)
California (482)
Canada (131)
China (35)
Colorado (25)
Connecticut (23)
Delaware (18)
Europe (3359)
Florida (62)
Georgia (14)
Idaho (1)
Illinois (38)
India (2)
Indiana (35)
Japan (13)
Kansas (6)
Kentucky (4)
Louisiana (7)
Maine (6)
Maryland (68)
Massachusetts (333)
Michigan (12)
Minnesota (21)
Missouri (2)
Montana (1)
Nebraska (1)
Nevada (10)
New Hampshire (5)
New Jersey (193)
New York (148)
North Carolina (80)
Northern California (263)
Ohio (18)
Pennsylvania (131)
South America (38)
Southern California (184)
Tennessee (7)
Texas (67)
United States (1870)
Utah (31)
Virginia (7)
Washington D.C. (3)
Washington State (54)
Wisconsin (5)
24,071 Results for "155".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026
April 20, 2026
·
8 min read
Press Releases
Click Therapeutics and Boehringer Ingelheim Announce Series D Investment and Funding to Advance Commercialization of CT-155
April 9, 2026
·
8 min read
Press Releases
BoomRx Surpasses $15.5 Million in Net Order Revenue and 77,000+ Processed Orders in First Eight Months
March 4, 2026
·
3 min read
Press Releases
Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000
March 10, 2026
·
4 min read
Press Releases
Marble Raises $15.5M Series A to Scale Access to Youth Mental Health Care
October 15, 2025
·
3 min read
Mergers & acquisitions
Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy
Servier will pick up Ojemda, which received FDA approval in 2024 to treat pediatric glioma. The drug clocked sales of $155 million for Day One Biopharmaceuticals in 2025.
March 6, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155
October 29, 2025
·
7 min read
Job Creations
Massachusetts Tax Incentives for Moderna, Vertex and More Creating 1,155 Jobs
Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in Massachusetts. Moderna and Vertex received the largest awards and will add over 600 combined jobs.
October 24, 2024
·
4 min read
·
Angela Gabriel
Press Releases
Boehringer and Click Therapeutics present pivotal data for investigational prescription digital therapeutic CT-155 showing a statistically significant reduction in negative symptoms of schizophrenia
October 14, 2025
·
13 min read
Press Releases
Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
July 3, 2025
·
3 min read
1 of 2,408
Next
